These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36401737)

  • 1. Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey.
    Ferreira-da-Silva R; Alves JM; Vieira C; Silva AM; Marques J; Morato M; Polónia JJ; Ribeiro-Vaz I
    J Community Health; 2023 Apr; 48(2):295-308. PubMed ID: 36401737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.
    Toklu HZ; Uysal MK
    Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
    Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
    Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
    Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
    Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight.
    Elkalmi RM; Hassali MA; Ibrahim MI; Jamshed SQ; Al-Lela OQ
    J Patient Saf; 2014 Jun; 10(2):81-7. PubMed ID: 24618640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study.
    Shareef J; Sridhar SB; Bhupathyraaj M; Shariff A; Thomas S
    Ther Adv Drug Saf; 2024; 15():20420986241285930. PubMed ID: 39381061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Factors of Spontaneous Reporting of Adverse Drug Reactions among Community Pharmacists.
    Yu YM; Lee E; Koo BS; Jeong KH; Choi KH; Kang LK; Lee MS; Choi KH; Oh JM; Shin WG
    PLoS One; 2016; 11(5):e0155517. PubMed ID: 27192159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacovigilance Concept Knowledge, Perspectives and Attitudes: A Cross-Sectional Study Among Community Pharmacists.
    Abu Assab M; Alhamad H; Albahar F; Abu Dayyih W; Echarif S; Abu Assab H
    Inquiry; 2024; 61():469580241246464. PubMed ID: 38581250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country.
    Nduka SO; Ibe CO; Nwaodu MA; Robert CC
    Sci Rep; 2024 Jul; 14(1):16821. PubMed ID: 39039143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
    Zimmermann A; Gaworska-Krzeminska A; Flis A
    Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.